Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of CD07805/47 Gel on Rosacea Flushing
NCT02300129Phase 2Completed
- Sponsor
- Galderma
- Start
- Apr 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of brimonidine transdermal lotion in rosacea (4 arms), sponsored by Galderma. Primary endpoint: Total Number of Flushes for Each 2-week Period at Day 36. Started Apr 2014; status: completed.
02
Drugs
brimonidine transdermal lotion
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT02300129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02300129.